Amgen (AMGN) Launches Pavblu As Rival To Regeneron's (REGN) Eylea - Bloomberg
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) Launches Pavblu As Rival To Regeneron's (NASDAQ: REGN) Eylea - Bloomberg
- Amgen Comments In An Emailed Statement
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Warsh: Inflation Data Don’t Suggest Trend Meaningfully Improved
- Macy's (M) Declares $0.1915 Quarterly Dividend; 3.4% Yield
- NVIDIA (NVDA) call put ratio 1.8 calls to 1 put with a focus on a spreader of 10K August 28 weekly 220 calls, August 28 weekly 227.50 calls and September 4 weekly 240 calls
Create E-mail Alert Related Categories
Corporate News, LitigationRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
